BSE filing, NSE: EMBDL. Summary written from the filing by ALFA Finder's alert engine.
Embassy Developments Ltd: key numbers
- Share price
- ₹51.00
- Market cap
- ₹7,148 Cr
- Revenue (annual)
- ₹1,732 Cr
- Net profit (annual)
- ₹-872.6 Cr
- P/E (TTM)
- -7.6×Sector 34.0×
- Promoter holding
- 42.68%+0.03% QoQ
- FII holding
- 24.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Embassy Developments Ltd
All →Embassy Developments Convertible Warrants
Embassy Developments' promoter group entity converted 2.32 crore warrants into equity at INR 111.51 each. The conversion is valued at INR 258.70 crore.
- Value
- ₹258.7 Cr
Embassy Developments Convertible Warrants
Embassy Developments allotted 1,22,00,000 equity shares on conversion of preferential warrants. Paid-up capital rises by Rs 2.44 Crore to Rs 282.77 Crore.
- Value
- ₹2.44 Cr
Embassy Developments Convertible Warrants
Embassy Developments allotted 1,22,00,000 equity shares on conversion of promoter-group warrants, receiving Rs.102.03 Crore balance consideration. The conversion lifts promoter group holding to 43.62%.
- Value
- ₹102.0 Cr
Embassy Developments Convertible Warrants
Embassy Developments allotted 1.10 crore shares to a promoter entity on warrant conversion. Balance consideration of Rs.91.99 Crore received.
- Value
- ₹91.99 Cr
Embassy Developments Preferential Issue
Promoter entities disclosed acquisition of shares and warrants via preferential allotment, warrant conversion, and open market purchase, updating their total holdings in the company.
- Promoter stake change
- -0.65%
Embassy Developments Other Announcement
The company submitted the Regulation 74(5) certificate for the quarter ended September 30, 2026, confirming the dematerialization and rematerialization status of its securities.
Other board meeting date announcements
All →Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.
ESDS Software Solution Board Meeting Date
ESDS Software Solution will hold a board meeting on 2 November 2026 to consider unaudited standalone and consolidated results for Q2 and half-year. This is a prior intimation of a future meeting with no decision yet taken.